Switch to:

Beam Therapeutics Asset Impairment Charge

: $0.00 Mil (TTM As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Beam Therapeutics's Asset Impairment Charge for the three months ended in Mar. 2020 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2020 was $0.00 Mil.


Beam Therapeutics Asset Impairment Charge Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Asset Impairment Charge 0.00 0.00 0.00

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Asset Impairment Charge Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Beam Therapeutics Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2020 was 0 (Jun. 2019 ) + 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) = $0.00 Mil.


Beam Therapeutics Asset Impairment Charge Related Terms


Beam Therapeutics Asset Impairment Charge Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)